Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin

Aslınur Ozkaya-Parlakay1, Hasan Tezer2, Tugba Kazmacan3

  • 1Ankara Hematology Oncology Children's Training and Research Hospital, Pediatric Infectious Disease Unit, Ankara, Turkey aslinur.o@gmail.com.

Insights

Neonatal Candida infections, particularly from Candida parapsilosis, pose a significant risk. This case study shows caspofungin effectively treated a neonate with refractory Candida parapsilosis septicemia.

Area of Science:

  • Neonatology
  • Mycology
  • Infectious Diseases

Background:

  • Neonatal Candida infections are a major cause of morbidity and mortality.
  • Candida albicans is common, but Candida parapsilosis is an emerging threat in neonates.
  • Candida parapsilosis exhibits reduced susceptibility to echinocandins.

Observation:

  • A neonate presented with refractory septicemia caused by Candida parapsilosis.
  • Standard treatments were ineffective.

Findings:

  • The infant's refractory Candida parapsilosis septicemia was successfully treated with caspofungin.
  • This highlights caspofungin's efficacy in specific neonatal fungal infections.

Implications:

  • Caspofungin may be a valuable therapeutic option for difficult-to-treat Candida parapsilosis infections in neonates.
  • Further research into Candida parapsilosis treatment strategies is warranted.
  • This case contributes to understanding antifungal resistance and treatment in neonatal intensive care units.

Related Concept Videos